医学
放射性配体
药代动力学
前列腺腺癌
腺癌
核医学
放射科
泌尿科
内科学
癌症
受体
作者
Ryan Kohlbrenner,Xiao Wu,Hao G. Nguyen,Matthew R. Cooperberg,Tushar Chakravarty,Peter R. Carroll,Thomas A. Hope
出处
期刊:Radiology
[Radiological Society of North America]
日期:2024-08-01
卷期号:312 (2)
标识
DOI:10.1148/radiol.232544
摘要
Background Intravenous prostate-specific membrane antigen (PSMA)-targeted radioligand therapy improves survival in men with metastatic castration-resistant prostate cancer. Yet, the impact of selective prostatic arterial administration on primary tumor uptake is unclear. Purpose To compare gallium 68 (
科研通智能强力驱动
Strongly Powered by AbleSci AI